Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
2005
Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
147
Citations
NaN
KQI